SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
5 (648) In stock
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2
Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
The Omicron variant is highly resistant against antibody-mediated
Emerging SARS-CoV-2 variants of concern and potential intervention
Selection for immune evasion in SARS-CoV-2 revealed by high
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2
Determinants of de novo B cell responses to drifted epitopes in post-vaccination SARS-CoV-2 infections
Cooperative and structural relationships of the trimeric Spike with infectivity and antibody escape of the strains Delta (B.1.617.2) and Omicron (BA.2, BA.5, and BQ.1)
Design of the x3 disulfide bond to stabilise the SARS-CoV-2 spike in
